Literature DB >> 8907602

Stab wounds in Bulawayo, Zimbabwe: a four year audit.

G I Muguti1, C Zishiri, M Dube.   

Abstract

Between January 1989 and December 1992 a total of 102 patients (88 pc male and 12 pc female) were treated for stab wounds at Mpilo Central Hospital, Bulawayo, Zimbabwe. The case records of these patients have been studied retrospectively. The mean age of the patients was 30 years (Standard Deviation 9). Most of the patients, 82 pc (82/102) were residents of the city of Bulawayo with only 18 pc (18/102) coming from rural areas. The mean delay in presentation was 12 hours (SD 11). A knife was the stabbing instrument in most cases (82 pc). Fights, 38 pc (26/68), domestic disputes, 26 pc (18/68) and robbery 21 pc (14/68) were the commonest motives for stabbing. In most cases stabbing occurred in a beer hall, 47 pc (26/55) and at home, 31 pc (17/55). The majority of stab wounds occurred in the chest, 51 pc followed by the abdomen, 31 pc. Of the patients with stab wounds of the chest 22 pc (14/65) required intercostal chest drains. Of the 39 patients with stab wounds of the abdomen 20 patients were subjected to laparotomy. No abnormality was found at operation in 50 pc (10/20) of cases. No major complications or mortality were recorded in this series. Based on the findings in this study, there is need for us to adopt a more conservative approach to the management of stab wounds, especially those involving the abdomen. This policy of "selective conservatism" should be based on a thorough physical examination and appropriate special investigations. Active surgical intervention should be reserved for specific indications.

Entities:  

Mesh:

Year:  1995        PMID: 8907602

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  1 in total

1.  "Is this a dagger I see before me?"--an audit of stabbings and gunshot wounds in Limerick.

Authors:  J Shabbir; C O McDonnell; J B O'Sullivan; K Cahill; A Moore; R Raminlagan; G Quinn; P A Grace
Journal:  Ir J Med Sci       Date:  2004 Apr-Jun       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.